How to do a twin bag exchange
https://libcat.nshealth.ca/en/permalink/chpams34482
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 0633
- Available Online
- View Pamphlet
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Peritoneal Dialysis
- Subjects (LCSH)
- Peritoneal dialysis
- Specialty
- Nephrology
- Abstract
- This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0633
Day surgery peritoneal dialysis catheter insertion
https://libcat.nshealth.ca/en/permalink/chpams35158
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1226
- Available Online
- View Pamphlet
This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (18 p.) : digital, PDF file
- Subjects (MeSH)
- Hospital admission
- Peritoneal dialysis
- Kidney Diseases - surgery
- Preoperative Care
- Postoperative Care
- Subjects (LCSH)
- Peritoneal access
- Peritoneal dialysis
- Preoperative care
- Postoperative care
- Specialty
- Nephrology
- Hematology
- Abstract
- This pamphlet reviews what to expect before, during and after surgery for the insertion of a peritoneal dialysis catheter. Information includes how to get your bowels ready for surgery, what to bring to the hospital on the day of surgery, care of your incision/exit site and keeping your bowels regular after surgery. Information about peritoneal dialysis teaching is also provided.
- Responsibility
- prepared by: NSHA Renal Program
- Pamphlet Number
- 1226
Treatment of high potassium with Kayexalate powder in hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1445
- Available Online
- View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Polystyrene sulfonic acid
- Hyperkalemia
- Subjects (LCSH)
- Drugs
- Low-potassium diet
- Specialty
- Nephrology
- Medications
- Abstract
- Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Notes
- Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1445
Lanthanum (Fosrenol) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1466
- Available Online
- View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Lanthanum
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
- Notes
- Previous title: Fosrenol (Lanthanum) and hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1466
Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1465
- Available Online
- View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Cinacalcet
- Renal Insufficiency, Chronic - drug therapy
- Hyperparathyroidism, Secondary - drug therapy
- Subjects (LCSH)
- Chronic renal failure
- Hyperparathyroidism
- Kidneys--Diseases--Treatment
- Abstract
- Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
- Notes
- Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
- Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1465
Sevelamer (Renagel) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1464
- Available Online
- View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Sevelamer
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Abstract
- Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
- Notes
- Previous title: Renagel (Sevelamer) and Hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1464
Oral irons and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1469
- Available Online
- View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Oral irons and CKD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Renal Insufficiency, Chronic - drug therapy
- Anemia, Iron-Deficiency - drug therapy
- Abstract
- Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1469
Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1493
- Available Online
- View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Anemia - drug therapy
- Subjects (LCSH)
- Chronic renal failure--Complications
- Renal anemia
- Abstract
- Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1493
Injectable iron and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1495
- Available Online
- View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Iron - therapeutic use
- Kidney Diseases
- Anemia, Iron-Deficiency
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure--Complications
- Iron deficiency anemia
- Abstract
- Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Notes
- Previous title: Injectable iron sucrose and chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1495
Tums (calcium carbonate) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1514
- Available Online
- View Pamphlet
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Calcium Carbonate - therapeutic use
- Kidney Diseases - drug therapy
- Subjects (LCSH)
- Calcium carbonate
- Kidneys--Diseases
- Specialty
- Nephrology
- Abstract
- Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
- Notes
- Tums (calcium carbonate) and kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1514
Managing your fluid intake in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35545
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0538
- Available Online
- View Pamphlet
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - diet therapy
- Subjects (LCSH)
- Kidneys--Diseases--Nutritional aspects
- Abstract
- This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
- Notes
- Previous title: Managing your fluid intake in chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0538
Fistuloplasty
https://libcat.nshealth.ca/en/permalink/chpams35614
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0397
- Available Online
- View Pamphlet
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (LCSH)
- Fistula
- Therapeutic embolization
- Specialty
- Nephrology
- Abstract
- A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0397
Tunneled hemodialysis catheter
https://libcat.nshealth.ca/en/permalink/chpams35616
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1032
- Available Online
- View Pamphlet
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Vascular Access Devices
- Subjects (LCSH)
- Hemodialysis
- Catheters
- Specialty
- Nephrology
- Abstract
- A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1032
Non-tunneled hemodialysis catheter
https://libcat.nshealth.ca/en/permalink/chpams35618
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1093
- Available Online
- View Pamphlet
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Vascular Access Devices
- Subjects (LCSH)
- Catheters
- Hemodialysis
- Specialty
- Nephrology
- Abstract
- A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1093
Care of your arteriovenous fistula
https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0651
- Available Online
- View Pamphlet
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Central Venous Catheters
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Specialty
- Nephrology
- Abstract
- An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0651
Over-the-counter medications and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1636
- Available Online
- View Pamphlet
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Nonprescription Drugs
- Renal Insufficiency, Chronic - drug therapy
- Subjects (LCSH)
- Drugs, Nonprescription
- Chronic renal failure
- Abstract
- If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why you should not take any herbal or natural health products is included.
- Notes
- Previous title: Over-the-counter medications & chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1636
Dalteparin (Fragmin) to prevent clotting during hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1760
- Available Online
- View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Dalteparin
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Blood--coagulation
- Specialty
- Nephrology
- Abstract
- Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1760
Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease
https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1889
- Available Online
- View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Str…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (LCSH)
- Streptococcus pneumoniae
- Kidneys--Diseases
- Specialty
- Nephrology
- Abstract
- Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1889
Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease
https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1890
- Available Online
- View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Pneumococcal Vaccines
- Streptococcus pneumoniae
- Kidney Diseases
- Subjects (LCSH)
- Pneumococcal vaccine
- Streptococcus pneumoniae
- Kidneys--Diseases
- Specialty
- Nephrology
- Abstract
- Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1890
24-hour urine collection : split daytime and nightime
https://libcat.nshealth.ca/en/permalink/chpams36496
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1940
- Available Online
- View Pamphlet
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Urine Specimen Collection
- Specimen Handling
- Subjects (LCSH)
- Diagnostic specimens
- Urine--Collection and preservation
- Abstract
- Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
- Responsibility
- Prepared by: NSHA Renal Program
- Pamphlet Number
- 1940
